AYTU

Aytu BioScience, Inc.

 
Common Stock SEC Reporting - Current
OTCQX U.S.
Verified Company Profile 5/31/2017
Contact Info
  • 373 Inverness Parkway
  • Suite 206
  • Englewood, CO 80112

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2017 10-Q
CIK 0001385818
Fiscal Year End 6/30
OTC Marketplace OTCQX U.S.
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2015
Employees 53 a/o May 30, 2017
Company Officers/Contacts
Joshua Robert Disbrow CEO
Jarrett Disbrow COO
Gregory A. Gould CFO
Company Directors
Gary Cantrell Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
Carl C Dockery Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
John Donofrio, Jr. Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
Michael Emil Macaluso
Service Providers
Accounting/Auditing Firm
EKS&H
7979 E. Tufts Ave.
Suite 400
Denver, CO, 80237
United States
 
Securities Counsel
Wyrick Robbins Yates & Ponton LLP OTCQX Sponsor
4101 Lake Boone Trail
Suite 300
Raleigh, NC, 27607
United States
 
Investor Relations Firm
Amato and Partners, LLC
90 Park Ave
17th Floor
New York, NY,
United States
 
Company History
  • Sponsored for OTCQX by Wyrick Robbins Yates & Ponton LLP on 12/14/2015.
  • Formerly=Rosewind Corp. until 6-2015
AYTU Security Details Other Company Securities
Share Structure
Market Value1 $9,962,297 a/o Jun 26, 2017
Authorized Shares 100,000,000 a/o Jun 14, 2017
Outstanding Shares 16,466,607 a/o Jun 14, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 9,265,386 a/o Dec 01, 2016
Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders
Shareholders of Record 470 a/o Dec 01, 2016
Short Selling Data
Short Interest 11,472 (-7.74%)
Jun 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security